Russell Investments Group
BDTX icon

Russell Investments Group’s Black Diamond Therapeutics BDTX Stock Holding History

Russell Investments Group’s Portfolio BDTX Stock Details BDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.44K Buy
4,024
+3,774
+1,510% +$9.23K ﹤0.01% 3985
2026
Q1 		$533 Hold
250
– – ﹤0.01% 4099
2025
Q4 		$608 Hold
250
– – ﹤0.01% 4076
2025
Q3 		$948 Hold
250
– – ﹤0.01% 4050
2025
Q2 		$620 Buy
+250
New +$482 ﹤0.01% 3724
2021
Q1 		– Sell
-6,367
Closed -$204K – 3103
2020
Q4 		$204K Hold
6,367
– – ﹤0.01% 2751
2020
Q3 		$192K Buy
+6,367
New +$194K ﹤0.01% 2787

Other funds holding BDTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
RWM
Ritholtz Wealth Management New York $6.7B AUM 32.7% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
DIM
DLK Investment Management Solana Beach, California $235M AUM 12.41% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Russell Investments Group's BDTX Position: Q2 2026 in Review

Russell Investments Group increased its Black Diamond Therapeutics (BDTX) stake by 1,510% in Q2 2026, buying an estimated $9.23K and bringing the position to 4,024 shares worth $7.44K. The position accounts for ﹤0.01% of the portfolio, ranked #3985.

Russell Investments Group first reported a position in BDTX in Q3 2020 and has held it in 7 quarters since. The position peaked at $204K in Q4 2020. 31 funds tracked by Wall St. Rank hold BDTX as of Q2 2026.

  • Russell Investments Group held 4,024 shares of Black Diamond Therapeutics worth $7.44K as of Q2 2026.
  • Russell Investments Group bought 3,774 Black Diamond Therapeutics shares in Q2 2026, an estimated $9.23K.
  • Black Diamond Therapeutics made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #3985 holding.
  • Russell Investments Group first reported a position in Black Diamond Therapeutics in Q3 2020 and has held it in 7 quarters since.
  • Russell Investments Group's Black Diamond Therapeutics position peaked at $204K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.